Tech Company Financing Transactions

Gemphire Therapeutics Funding Round

Gemphire Therapeutics closed a $2.8 million funding round on 9/30/2015. Backers included Grand Angels and private investors.

Transaction Overview

Announced On
9/30/2015
Transaction Type
Venture Equity
Amount
$2,800,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
17199 N. Laurel Park Dr. 401
Livonia, MI 48152
USA
Email Address
Not Recorded
Overview
Gemphire Therapeutics (NASDAQ: GEMP) mission is to develop novel drugs, such as gemcabene, to treat the large, growing unmet need of dyslipidemia patients who are unable to reach optimal LDL cholesterol or triglyceride levels with statin or other therapies.
Profile
Gemphire Therapeutics LinkedIn Company Profile
Social Media
Gemphire Therapeutics Company Twitter Account
Company News
Gemphire Therapeutics News
Facebook
Gemphire Therapeutics on Facebook
YouTube
Gemphire Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Steve Gullans
  Steve Gullans LinkedIn Profile  Steve Gullans Twitter Account  Steve Gullans News  Steve Gullans on Facebook
Chief Financial Officer
Jeff Mathiesen
  Jeff Mathiesen LinkedIn Profile  Jeff Mathiesen Twitter Account  Jeff Mathiesen News  Jeff Mathiesen on Facebook
Chief Medical Officer
Lee Golden
  Lee Golden LinkedIn Profile  Lee Golden Twitter Account  Lee Golden News  Lee Golden on Facebook
Chief Scientific Officer
Charles Bisgaier
  Charles Bisgaier LinkedIn Profile  Charles Bisgaier Twitter Account  Charles Bisgaier News  Charles Bisgaier on Facebook
VP - Finance
Amy Rabourn
  Amy Rabourn LinkedIn Profile  Amy Rabourn Twitter Account  Amy Rabourn News  Amy Rabourn on Facebook
VP - Manufacturing
Daniela Oniciu
  Daniela Oniciu LinkedIn Profile  Daniela Oniciu Twitter Account  Daniela Oniciu News  Daniela Oniciu on Facebook
VP - Operations
Liz Masson
  Liz Masson LinkedIn Profile  Liz Masson Twitter Account  Liz Masson News  Liz Masson on Facebook
VP - R & D
Daniela Oniciu
  Daniela Oniciu LinkedIn Profile  Daniela Oniciu Twitter Account  Daniela Oniciu News  Daniela Oniciu on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/30/2015: Confluent venture capital transaction
Next: 9/30/2015: Socrates Health Solutions venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We report on funding rounds that are announced publicly. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary